Close relationship between redox state of human serum albumin and serum cysteine levels in non-diabetic CKD patients with various degrees of renal function

Clinical Nephrology

Volumn 82, Issue 5, 2014, Pages 320-325

  Suzuki, Yoshihumi ^a   Suda, Kenji ^a   Matsuyama, Yukie ^b   Era, Seiichi ^b   Soejima, Akinori ^a  

^a KYORIN UNIVERSITY   (Japan)

^b GIFU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Cysteine; Homocysteine; Human mercaptalbumin; Primary glomerulonephritis

Indexed keywords

ALBUMIN; CYSTEINE; HOMOCYSTEINE; HUMAN MERCAPTALBUMIN; HUMAN SERUM ALBUMIN; THIOL; UNCLASSIFIED DRUG; MERCAPTOALBUMIN; SERUM ALBUMIN;

ADULT; ARTICLE; BLOOD LEVEL; CHRONIC KIDNEY DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GLOMERULONEPHRITIS; GLOMERULUS FILTRATION RATE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; ION MONITORING; KIDNEY DYSFUNCTION; KIDNEY FUNCTION; MALE; MASS FRAGMENTOGRAPHY; OXIDATION REDUCTION STATE; AGED; BLOOD; CASE CONTROL STUDY; CHRONIC KIDNEY FAILURE; METABOLISM; MIDDLE AGED; OXIDATION REDUCTION REACTION; RISK FACTOR;

ADULT; AGED; CASE-CONTROL STUDIES; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CYSTEINE; FEMALE; GLOMERULAR FILTRATION RATE; HOMOCYSTEINE; HUMANS; MALE; MIDDLE AGED; OXIDATION-REDUCTION; RENAL INSUFFICIENCY, CHRONIC; RISK FACTORS; SERUM ALBUMIN;

EID: 84909646997     PISSN: 03010430     EISSN: None     Source Type: Journal    
DOI: 10.5414/CN108040     Document Type: Article

References (20)

1. Soejima A, Matsuzawa N, Miyake N, Karube M, Fukuoka K, Nakabayashi K, Kitamoto K, Nagasawa T. Hypoalbuminemia accelerates erythrocyte membrane lipid peroxidation in chronic hemodialysis patients. Clin Nephrol. 1999; 51: 92-97.
2. Soejima A, Kaneda F, Manno S, Matsuzawa N, Kouji H, Nagasawa T, Era S, Takakuwa Y. Useful markers for detecting decreased serum antioxidant activity in hemodialysis patients. Am J Kidney Dis. 2002; 39: 1040-1046.
3. Mansoor MA, Svardal AM, Ueland PM. Determination of the in vivo redox status of cysteine, cysteinylglycine, homocysteine, and glutathione in human plasma. Anal Biochem. 1992; 200: 218-229.
4. Himmelfarb J, McMenamin E, McMonagle E. Plasma aminothiol oxidation in chronic hemodialysis patients. Kidney Int. 2002; 61: 705-716.
5. Van Den Brandhof WE, Haks K, Schouten EG, Verhoef P. The relation between plasma cysteine, plasma homocysteine and coronary atherosclerosis. Atherosclerosis. 2001; 157: 403-409.
6. Suliman ME, Anderstam B, Lindholm B, Bergström J. Total, free, and protein-bound sulphur amino acids in uraemic patients. Nephrol Dial Transplant. 1997; 12: 2332-2338.
7. Suliman ME, Stenvinkel P, Qureshi AR, Bárány P, Heimburger O, Anderstam B, Alvestrand A, Lindholm B. Hyperhomocysteinemia in relation to plasma free amino acids, biomarkers of inflammation and mortality in patients with chronic kidney disease starting dialysis therapy. Am J Kidney Dis. 2004; 44: 455-465.
8. Soejima A, Matsuzawa N, Hayashi T, Kimura R, Ootsuka T, Fukuoka K, Yamada A, Nagasawa T, Era S. Alteration of redox state of human serum albumin before and after hemodialysis. Blood Purif. 2004; 22: 525-529.
9. Era S, Hamaguchi T, Sogami M, Kuwata K, Suzuki E, Miura K, Kawai K, Kitazawa Y, Okabe H, Noma A, Miyata S. Further studies on the resolution of human mercapt- and nonmercaptalbumin and on human serum albumin in the elderly by high-performance liquid chromatography. Int J Pept Protein Res. 1988; 31: 435-442.
10. Imai H, Era S, Hayashi T, Negawa T, Matsuyama Y, Okihara K, Nakatsuma A, Yamada H. Effect of propolis supplementation on the redox state of human serum albumin during high-intensity kendo training. Adv Exerc Sports Physiol. 2005; 11: 109-113.
11. Iseki K, Kawazoe N, Fukiyama K. Serum albumin is a strong predictor of death in chronic dialysis patients. Kidney Int. 1993; 44: 115-119.
12. Shinohara Y, Hasegawa H, Tagoku K, Hashimoto T. Simultaneous determination of methionine and total homocysteine in human plasma by gas chromatography-mass spectrometry. J Chromatogr B Biomed Sci Appl. 2001; 758: 283-288.
13. Shinohara Y, Hasegawa H, Ogawa K, Tagoku K, Hashimoto T. Distinct effects of folate and choline deficiency on plasma kinetics of methionine and homocysteine in rats. Metabolism. 2006; 55: 899-906.
14. Imai E, Horio M, Nitta K, Yamagata K, Iseki K, Hara S, Ura N, Kiyohara Y, Hirakata H, Watanabe T, Moriyama T, Ando Y, Inaguma D, Narita I, Iso H, Wakai K, Yasuda Y, Tsukamoto Y, Ito S, Makino H, et al. Estimation of glomerular filtration rate by the MDRD study equation modified for Japanese patients with chronic kidney disease. Clin Exp Nephrol. 2007; 11: 41-50.
15. Foley RN, Parfrey PS, Sarnak MJ. Clinical epidemiology of cardiovascular disease in chronic renal disease. Am J Kidney Dis. 1998; 32 (Suppl 3): S112-S119.
16. Stenvinkel P, Pecoits-Filho R, Lindholm B. Coronary artery disease in end-stage renal disease: no longer a simple plumbing problem. J Am Soc Nephrol. 2003; 14: 1927-1939.
17. Brunetti M, Terracina L, Timio M, Saronio P, Capodicasa E. Plasma sulfate concentration and hyperhomocysteinemia in hemodialysis patients. J Nephrol. 2001; 14: 27-31.
18. Wlodek PJ, Iciek MB, Milkowski A, Smolenski OB. Various forms of plasma cysteine and its metabolites in patients undergoing hemodialysis. Clin Chim Acta. 2001; 304: 9-18.
19. Sjöberg B, Anderstam B, Suliman M, Alvestrand A. Plasma reduced homocysteine and other aminothiol concentrations in patients with CKD. Am J Kidney Dis. 2006; 47: 60-71.
20. Kawakami A, Kubota K, Yamada N, Tagami U, Takehana K, Sonaka I, Suzuki E, Hirayama K. Identification and characterization of oxidized human serum albumin. A slight structural change impairs its ligand-binding and antioxidant functions. FEBS J. 2006; 273: 3346-3357.